0001209191-21-020592.txt : 20210315 0001209191-21-020592.hdr.sgml : 20210315 20210315193818 ACCESSION NUMBER: 0001209191-21-020592 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ryali Sriram CENTRAL INDEX KEY: 0001762893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 21743132 MAIL ADDRESS: STREET 1: C/O EIGER BIOPHARMACEUTICALS, INC. STREET 2: 2155 PARK BLVD. CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-12 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001762893 Ryali Sriram C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 0 1 0 0 Chief Financial Officer Common Stock 2021-03-12 4 A 0 16250 0.00 A 18152 D Stock Option (Right to Buy) 9.99 2021-03-12 4 A 0 97500 0.00 A 2031-03-11 Common Stock 97500 97500 D Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021. Includes 274 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021. The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date. /s/ Sriram Ryali 2021-03-15